{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:08:20Z","timestamp":1789834100381,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.transproceed.2023.12.010","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T10:54:26Z","timestamp":1708080866000},"page":"380-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"56","author":[{"given":"Eleni","family":"Gavriilaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Mallouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Laspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Lazaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Varelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Baldoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Demosthenous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Bousiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Batsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Gkioula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Sakellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.12.010_bib0001","series-title":"New insights in hematopoietic cell transplantation","first-page":"29","article-title":"Hematopoietic stem cell transplantation: historical perspectives","author":"Sakellari","year":"2010"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0002","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood.V126.23.1953.1953","article-title":"Gut microbiome changes after stem cell transplantation","volume":"126","author":"Chiusolo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0003","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0004","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JOP.18.00366","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary","volume":"14","author":"Taplitz","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0006","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0007","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0008","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/52.2.401","article-title":"Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora","volume":"52","author":"van Bekkum","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01969527","article-title":"Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation","volume":"9","author":"Vossen","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bbmt.2020.05.011","article-title":"The impact of antibiotic-mediated modification of the intestinal microbiome on outcomes of allogeneic hematopoietic cell transplantation: systematic review and meta-analysis","volume":"26","author":"Gavriilaki","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0011","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V93.10.3267.410k22_3267_3275","volume":"93","author":"Beelen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11899-018-0435-0","article-title":"Rethinking antimicrobial prophylaxis in the transplant patient in the world of emerging resistant organisms-where are we today?","volume":"13","author":"Horton","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0013","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.jtct.2021.12.012","article-title":"Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure","volume":"28","author":"Daoud-Asfour","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.mayocp.2015.04.016","article-title":"Therapeutic effects and mechanisms of action of rifaximin in gastrointestinal diseases","volume":"90","author":"DuPont","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0016","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bmt.2016.66","article-title":"Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation","volume":"51","author":"Weber","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.010_bib0017","unstructured":"Qayed M. Rifaximin for infection prophylaxis in hematopoietic stem cell transplantation, https:\/\/clinicaltrials.gov\/study\/NCT03529825; 2021 [accessed 09.08.23]."},{"key":"10.1016\/j.transproceed.2023.12.010_bib0018","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00277-021-04569-x","article-title":"Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation","volume":"100","author":"Marzuttini","year":"2021","journal-title":"Ann Hematol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:46:49Z","timestamp":1758577609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0041134524000721"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.010","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}